Candriam SCA’s Exelon EXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.3M | Sell |
1,252,767
-748,590
| -37% | -$34.6M | 0.26% | 80 |
|
|
2026
Q1 | $98.1M | Buy |
2,001,357
+798,748
| +66% | +$37.2M | 0.51% | 38 |
|
|
2025
Q4 | $52.4M | Buy |
1,202,609
+4,566
| +0.4% | +$208K | 0.26% | 88 |
|
|
2025
Q3 | $53.9M | Sell |
1,198,043
-5,656
| -0.5% | -$248K | 0.28% | 82 |
|
|
2025
Q2 | $52.3M | Buy |
1,203,699
+1,047,459
| +670% | +$46.6M | 0.3% | 80 |
|
|
2025
Q1 | $7.2M | Sell |
156,240
-22,827
| -13% | -$954K | 0.05% | 274 |
|
|
2024
Q4 | $6.74M | Buy |
179,067
+27,975
| +19% | +$1.09M | 0.04% | 315 |
|
|
2024
Q3 | $6.13M | Buy |
151,092
+10,532
| +7% | +$396K | 0.04% | 331 |
|
|
2024
Q2 | $4.86M | Buy |
140,560
+22,463
| +19% | +$829K | 0.03% | 343 |
|
|
2024
Q1 | $4.44M | Sell |
118,097
-394,539
| -77% | -$14.1M | 0.03% | 361 |
|
|
2023
Q4 | $18.4M | Buy |
512,636
+386,987
| +308% | +$14.9M | 0.13% | 166 |
|
|
2023
Q3 | $4.75M | Sell |
125,649
-166
| -0.1% | -$6.76K | 0.03% | 313 |
|
|
2023
Q2 | $5.13M | Sell |
125,815
-198,957
| -61% | -$8.22M | 0.04% | 330 |
|
|
2023
Q1 | $12.5M | Buy |
324,772
+220,620
| +212% | +$9.2M | 0.09% | 227 |
|
|
2022
Q4 | $4.5M | Sell |
104,152
-4,482
| -4% | -$177K | 0.03% | 404 |
|
|
2022
Q3 | $4.07M | Sell |
108,634
-48,043
| -31% | -$2.12M | 0.03% | 425 |
|
|
2022
Q2 | $7.1M | Buy |
156,677
+17,368
| +12% | +$817K | 0.06% | 277 |
|
|
2022
Q1 | $6.63M | Buy |
139,309
+4,824
| +4% | +$204K | 0.05% | 311 |
|
|
2021
Q4 | $5.54M | Sell |
134,485
-30,658
| -19% | -$1.15M | 0.04% | 346 |
|
|
2021
Q3 | $5.69M | Sell |
165,143
-11,415
| -6% | -$390K | 0.04% | 378 |
|
|
2021
Q2 | $5.58M | Buy |
176,558
+4,722
| +3% | +$152K | 0.04% | 381 |
|
|
2021
Q1 | $4.97M | Hold |
171,836
| – | – | 0.04% | 376 |
|
|
2020
Q4 | $5.17M | Buy |
171,836
+15,980
| +10% | +$472K | 0.04% | 385 |
|
|
2020
Q3 | $3.98M | Sell |
155,856
-944
| -0.6% | -$25K | 0.04% | 387 |
|
|
2020
Q2 | $4.06M | Sell |
156,800
-47,582
| -23% | -$1.26M | 0.04% | 376 |
|
|
2020
Q1 | $6.5M | Hold |
204,382
| – | – | 0.07% | 289 |
|
|
2019
Q4 | $6.65M | Sell |
204,382
-6,168
| -3% | -$200K | 0.07% | 295 |
|
|
2019
Q3 | $7.25M | Sell |
210,550
-21,471
| -9% | -$721K | 0.1% | 244 |
|
|
2019
Q2 | $7.9M | Sell |
232,021
-82,216
| -26% | -$2.9M | 0.1% | 231 |
|
|
2019
Q1 | $11.2M | Buy |
314,237
+162,493
| +107% | +$5.53M | 0.14% | 166 |
|
|
2018
Q4 | $4.88M | Buy |
151,744
+20,399
| +16% | +$652K | 0.08% | 286 |
|
|
2018
Q3 | $4.09M | Buy |
131,345
+442
| +0.3% | +$13.6K | 0.05% | 365 |
|
|
2018
Q2 | $3.98M | Buy |
130,903
+13,523
| +12% | +$387K | 0.06% | 342 |
|
|
2018
Q1 | $3.27M | Buy |
117,380
+15,375
| +15% | +$415K | 0.06% | 372 |
|
|
2017
Q4 | $2.87M | Buy |
102,005
+17,010
| +20% | +$489K | 0.05% | 385 |
|
|
2017
Q3 | $2.28M | Sell |
84,995
-20,203
| -19% | -$540K | 0.04% | 434 |
|
|
2017
Q2 | $2.71M | Buy |
105,198
+3,474
| +3% | +$88.4K | 0.05% | 400 |
|
|
2017
Q1 | $2.61M | Buy |
101,724
+19,481
| +24% | +$496K | 0.05% | 389 |
|
|
2016
Q4 | $2.08M | Buy |
82,243
+4,530
| +6% | +$107K | 0.05% | 364 |
|
|
2016
Q3 | $1.84M | Buy |
77,713
+15,673
| +25% | +$394K | 0.04% | 371 |
|
|
2016
Q2 | $1.61M | Buy |
62,040
+10,228
| +20% | +$253K | 0.04% | 349 |
|
|
2016
Q1 | $1.32M | Sell |
51,812
-11,600
| -18% | -$260K | 0.03% | 385 |
|
|
2015
Q4 | $1.26M | Sell |
63,412
-80,890
| -56% | -$1.64M | 0.03% | 363 |
|
|
2015
Q3 | $3.06M | Sell |
144,302
-277,982
| -66% | -$6.25M | 0.08% | 274 |
|
|
2015
Q2 | $9.46M | Sell |
422,284
-77,556
| -16% | -$1.86M | 0.2% | 149 |
|
|
2015
Q1 | $12M | Buy |
499,840
+148,587
| +42% | +$3.68M | 0.24% | 122 |
|
|
2014
Q4 | $9.29M | Buy |
+351,253
| New | +$9.01M | 0.19% | 151 |
|
Other funds holding EXC
Candriam SCA's EXC Position: Q2 2026 in Review
Candriam SCA reduced its Exelon (EXC) stake by 37% in Q2 2026, selling an estimated $34.6M and leaving 1,252,767 shares worth $58.3M. The position accounts for 0.26% of the portfolio, ranked #80.
Candriam SCA first reported a position in EXC in Q4 2014 and has held it in 47 quarters since. The position peaked at $98.1M in Q1 2026. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.
- Candriam SCA held 1,252,767 shares of Exelon worth $58.3M as of Q2 2026.
- Candriam SCA sold 748,590 Exelon shares in Q2 2026, an estimated $34.6M.
- Exelon made up 0.26% of Candriam SCA's portfolio in Q2 2026, its #80 holding.
- Candriam SCA first reported a position in Exelon in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Exelon position peaked at $98.1M in Q1 2026.
- 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.